- Report
- May 2022
- 203 Pages
Global
From €4768EUR$4,799USD£3,964GBP
- Report
- March 2022
- 220 Pages
Global
From €4768EUR$4,799USD£3,964GBP
- Report
- March 2022
- 180 Pages
Global
From €4768EUR$4,799USD£3,964GBP
- Report
- January 2022
- 210 Pages
Global
From €4768EUR$4,799USD£3,964GBP
- Report
- June 2021
- 191 Pages
Global
From €4768EUR$4,799USD£3,964GBP
- Report
- August 2023
- 1500 Pages
Global
From €8693EUR$8,750USD£7,227GBP
- Report
- April 2023
- 131 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- March 2023
- 56 Pages
Global
From €3725EUR$3,750USD£3,097GBP
- Report
- December 2022
- 211 Pages
Global
From €5961EUR$6,000USD£4,956GBP
- Report
- October 2022
- 348 Pages
Indonesia, Malaysia, Singapore Indonesia, Malaysia, Singapore
From €4967EUR$5,000USD£4,130GBP
- Report
- October 2022
- 220 Pages
United States
From €4967EUR$5,000USD£4,130GBP
- Report
- September 2022
- 144 Pages
Global
From €5961EUR$6,000USD£4,956GBP
- Report
- August 2022
- 96 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- May 2022
- 102 Pages
Africa, Middle East
From €4967EUR$5,000USD£4,130GBP
- Report
- December 2022
- 437 Pages
Global
From €4917EUR$5,123USD£3,950GBP
- Report
- September 2023
- 353 Pages
Global
From €4917EUR$5,123USD£3,950GBP
- Report
- March 2023
- 185 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- September 2022
- 291 Pages
Global
From €4222EUR$4,250USD£3,510GBP
- Report
- June 2021
- 203 Pages
Global
From €4222EUR$4,250USD£3,510GBP
- Report
- October 2023
- 193 Pages
Global
From €4471EUR$4,500USD£3,717GBP
The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more